Accuray (ARAY)

NASDAQ: ARAY · Real-Time Price · USD

1.36

-0.19 (-12.26%)

At close: May 01, 2025, 3:59 PM

1.36

0.00%

After-hours: May 01, 2025, 05:36 PM EDT

-12.26% (1D)

Bid	1.35
Market Cap	139.85M
Revenue (ttm)	465.25M
Net Income (ttm)	673K
EPS (ttm)	-0.04
PE Ratio (ttm)	-34
Forward PE	15.5
Analyst	n/a

Ask	1.39
Volume	2,248,750
Avg. Volume (20D)	652,157
Open	1.55
Previous Close	1.55
Day's Range	1.33 - 1.56
52-Week Range	1.33 - 2.95
Beta	1.31

About ARAY

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and m...

[Read more]

Industry Medical - Specialties

Sector Healthcare

IPO Date Feb 8, 2007

Employees 987

Stock Exchange NASDAQ

Ticker Symbol ARAY

Website https://www.accuray.com

Full Company Profile

Earnings Surprise

New

Accuray has released their quartely earnings on Apr 30, 2025:

Revenue of $113.24M exceeds estimates by $11.71M, with 11.98% YoY growth.

EPS of -0.01 exceeds estimates by 0.04, with 83.33% YoY growth.

Why Price Moved

3 hours ago New

Accuray shares are trading lower after the company... Unlock content with Pro Subscription

2 months ago

+8.03%

Accuray shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.

News

9 hours ago · zacks.com

ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y

Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.

Just now · seekingalpha.com

Accuray Incorporated (ARAY) Q3 2025 Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY ) Q3 2025 Earnings Call April 30, 2025 4:30 PM ET Company Participants Jesse Chew - Chief Legal Officer Suzanne Winter - President and Chief Executive Officer Ali Per...

1 day ago · zacks.com

Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates

Accuray (ARAY) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.06 per share a year ago.

3 weeks ago · zacks.com

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

ARAY continues to witness strength in its flagship CyberKnife system, along with robust global performance.

2 months ago · zacks.com

ARAY Stock Up as Q2 Earnings & Revenues Beat Estimates, Margins Up

Accuray delivers solid fiscal second-quarter results, witnessing growth in Product revenues and reduced operating expenses.

2 months ago · seekingalpha.com

Accuray Incorporated (ARAY) Q2 2025 Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY ) Q2 2025 Results Conference Call February 5, 2025 4:30 PM ET Company Participants Jesse Chew - Chief Legal Officer Suzanne Winter - President and Chief Executive Off...

2 months ago · zacks.com

Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Accuray (ARAY) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stre...

2 months ago · zacks.com

Accuray (ARAY) Q2 Earnings and Revenues Top Estimates

Accuray (ARAY) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.10 per share a year ago.